Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Finished Goods (2020 - 2022)

Rapid Micro Biosystems (RPID) has disclosed Finished Goods for 3 consecutive years, with $8.0 million as the latest value for Q2 2022.

  • Quarterly Finished Goods rose 165.47% to $8.0 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $8.0 million through Jun 2022, up 165.47% year-over-year, with the annual reading at $4.3 million for FY2021, 321.25% up from the prior year.
  • Finished Goods hit $8.0 million in Q2 2022 for Rapid Micro Biosystems, up from $5.9 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $8.0 million in Q2 2022 to a low of $1.0 million in Q4 2020.
  • Historically, Finished Goods has averaged $4.2 million across 3 years, with a median of $3.7 million in 2021.
  • Biggest five-year swings in Finished Goods: surged 321.25% in 2021 and later surged 165.47% in 2022.
  • Year by year, Finished Goods stood at $1.0 million in 2020, then soared by 321.25% to $4.3 million in 2021, then skyrocketed by 86.28% to $8.0 million in 2022.
  • Business Quant data shows Finished Goods for RPID at $8.0 million in Q2 2022, $5.9 million in Q1 2022, and $4.3 million in Q4 2021.